Lv11
4 积分 2022-09-14 加入
First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
1小时前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
6小时前
已完结
Cancer burden and control in China: landscape, trends and challenges
7小时前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
18天前
已完结
Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer
26天前
已完结
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
26天前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
26天前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial
26天前
已完结
Correspondence - Tranexamic acid for traumatic brain injury
27天前
已完结
Kit Expression in Small Cell Carcinomas of the Lung: Effects of Chemotherapy
28天前
已完结
皖公网安备34019202002308
